Baricitinib vs Tirzepatide

Baricitinib vs Tirzepatide: Overview

This comparison examines the pharmacological differences between Baricitinib and Tirzepatide.

Mechanism of Action

Baricitinib: Selective JAK1 and JAK2 inhibitor blocking cytokine signaling involved in inflammation.

Tirzepatide: Dual GIP and GLP-1 receptor agonist.

Pharmacokinetics

Half-life: Baricitinib — 12 hours; Tirzepatide — 5 days.

Chemical Properties

Molecular Formula: Baricitinib — C16H17N7O2S.

Molecular Weight: Baricitinib — 371.4170 g/mol.

Type: Baricitinib — Small molecule; Tirzepatide — Protein.